For R&D use only.

Dabrafenib

  • Catalog NO.:A852141
  • CAS No. : 1195765-45-7
  • Molecular Formula:C23H20F3N5O2S2
  • Molecular Weight: 519.56
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS
SDS COA HPLC/GC NMR

Product Details

CAS Number 1195765-45-7 Appearance White powder
Catalog Number A852141 MDL Number MFCD17215684
Molecular Formula C23H20F3N5O2S2 Molecular Weight 519.56
Boiling Point Melting Point
Flash Point Density
Synonyms N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements H302-H315-H319-H335 Class
Precautionary Statements P261-P305+P351+P338 Packing Group

Description

Dabrafenib, also known as GSK2118436 , is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations. On May 29, 2013, FDA approved this drug.

1195765-45-7 (free base)

1195768-06-9 (mesylate)

Related Products

My Tracks: Dabrafenib
Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

Dabrafenib
N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide